ConductScience.org, home

Paper41398138

Targeting RUNX1 Germline Variants: Agents Under Investigation.

Ghalamkari S and 5 others. Curr Hematol Malig Rep, 2025. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Targeting RUNX1 Germline Variants: Agents Under Investigation. Papers, record 41398138. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41398138

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Targeting RUNX1 Germline Variants: Agents Under Investigation.
PubMed
Journal
Curr Hematol Malig Rep
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-11-05
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ghalamkari SSaman
2Hahn CNChristopher N
3Lau AAmelia
4Scott HSHamish S
5Homan CCClaire C
6Brown ALAnna L

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Core Binding Factor Alpha 2 SubunitMajor topic
Germ-Line MutationMajor topic
Hematologic NeoplasmsMajor topic
Myeloproliferative DisordersMajor topic
Humans
Animals
Molecular Targeted Therapy
Signal Transduction
Genetic Predisposition to Disease

Source PubMed

Download CSV of topics

References67

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
125114263Targeted correction of RUNX1 mutation in FPD patient-specific induced pluripotent stem cells rescues megakaryopoietic defects.Blood2014https://conductscience.org/library/papers/25114263PubMed
226165925Runx1 Deficiency Decreases Ribosome Biogenesis and Confers Stress Resistance to Hematopoietic Stem and Progenitor Cells.Cell Stem Cell2015https://conductscience.org/library/papers/26165925PubMed
333283989CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia.N Engl J Med2021https://conductscience.org/library/papers/33283989PubMed
437435412Donor Cell Leukemia Following Allogeneic Hematopoietic Stem Cell Transplantation.J Hematol2023https://conductscience.org/library/papers/37435412PubMed
511675361A novel CBFA2 single-nucleotide mutation in familial platelet disorder with propensity to develop myeloid malignancies.Blood2001https://conductscience.org/library/papers/11675361PubMed
638661449Exagamglogene Autotemcel for Severe Sickle Cell Disease.N Engl J Med2024https://conductscience.org/library/papers/38661449PubMed
732208489RUNX1-mutated families show phenotype heterogeneity and a somatic mutation profile unique to germline predisposed AML.Blood Adv2020https://conductscience.org/library/papers/32208489PubMed
836322931A RUNX1-FPDMM rhesus macaque model reproduces the human phenotype and predicts challenges to curative gene therapies.Blood2023https://conductscience.org/library/papers/36322931PubMed
919230772Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study.Lancet Oncol2009https://conductscience.org/library/papers/19230772PubMed
1021941284A decade of exploring the cancer epigenome - biological and translational implications.Nat Rev Cancer2011https://conductscience.org/library/papers/21941284PubMed
1139822266
Casgevy (exagamglogene autotemcel) and Lyfgenia (lovotibeglogene autotemcel) for individuals 12 years and older with sickle cell disease (SCD) and recurrent vaso-occlusive crises (VOC): A therapeutics bulletin of the American College of Medical Genetics and Genomics (ACMG).
Genet Med Open2024https://conductscience.org/library/papers/39822266PubMed
1239822584Disease characteristics and outcomes of acute myeloid leukemia in germline RUNX1 deficiency (Familial Platelet Disorder with associated Myeloid Malignancy).Hemasphere2025https://conductscience.org/library/papers/39822584PubMed
1329730354The nonreceptor tyrosine kinase c-Abl phosphorylates Runx1 and regulates Runx1-mediated megakaryocyte maturation.Biochim Biophys Acta Mol Cell Res2018https://conductscience.org/library/papers/29730354PubMed
1439078402Update on Recommendations for Surveillance for Children with Predisposition to Hematopoietic Malignancy.Clin Cancer Res2024https://conductscience.org/library/papers/39078402PubMed
1535797463Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN.Blood2022https://conductscience.org/library/papers/35797463PubMed
1638019014Genomic landscape of patients with germline RUNX1 variants and familial platelet disorder with myeloid malignancy.Blood Adv2024https://conductscience.org/library/papers/38019014PubMed
1715164071Epigenetics in human disease and prospects for epigenetic therapy.Nature2004https://conductscience.org/library/papers/15164071PubMed
1837464068Dual intron-targeted CRISPR-Cas9-mediated disruption of the AML RUNX1-RUNX1T1 fusion gene effectively inhibits proliferation and decreases tumor volume in vitro and in vivo.Leukemia2023https://conductscience.org/library/papers/37464068PubMed
1935131736RUNX1 overexpression triggers TGF-β signaling to upregulate p15 and thereby blocks early hematopoiesis by inducing cell cycle arrest.Stem Cell Res2022https://conductscience.org/library/papers/35131736PubMed
2029296817RUNX1 regulates site specificity of DNA demethylation by recruitment of DNA demethylation machineries in hematopoietic cells.Blood Adv2017https://conductscience.org/library/papers/29296817PubMed

See all 67 referencesDownload CSV of references

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
MTOR2475PubTator's text mininghttps://conductscience.org/library/genes/2475NCBI Gene
RUNX1861PubTator's text mininghttps://conductscience.org/library/genes/861NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41398138

GET https://conductscience.org/api/papers/v1/41398138/references?page=2